Structure |
Chemical Name |
CAS |
MF |
 |
Sitafloxacin Impurity ZZ-B-01 |
|
|
 |
Tofacitinib Impurity 3 |
1206825-36-6 |
C13H19N5 |
 |
Tofacitinib Impurity 89 |
|
|
 |
Nintedanib Impurity L |
2095596-44-2 |
C31H33N5O4 |
 |
Rizatriptan EP Impurity A |
887001-08-3 |
C28H35N7 |
 |
Dapoxetine iMpurity |
38262-42-9 |
C11H10O3S |
 |
Saxagliptin Impurity 9 |
|
|
 |
(1r,4r)-4-((2-aminobenzyl)amino)cyclohexanol |
15992-77-5 |
C15H22N2O5 |
 |
Moxifloxacin degrade Impurity |
|
|
 |
Edaravone Impurity 17 |
|
|
 |
Capecitabine impurity 7 |
|
|
 |
Linagliptin Impurity 46 |
|
|
 |
((3R,5S,E)-3,5-dihydroxy-7-(4-isopropyl-2-(N-methylmethylsulfonamido)-6-phenylpyrimidin-5-yl)hept-6-enoate)calcium(II) |
|
C44H56CaN6O12S2 |
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1932275-13-2 |
C10H9F2NO |
 |
(3R,5S,Z)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid calcium(II) |
1445208-17-2 |
C22H28FN3O6S |
 |
Tafluprost Impurity 7 |
733036-94-7 |
C25H35FO5 |
 |
Tropisetron Impurity 1 |
|
|
 |
Fosaprepitant Impurity DBJ |
|
|
 |
Cabozantinib impurity 29 |
|
|
 |
Cabozantinib impurity 34 |
|
|
 |
Carfilzomib Impurity YGH |
|
|
 |
Ondansetron Impurity 3 |
|
|
 |
Irsogladine Impurity GDT |
|
|
 |
Carvedilol Impurity NH |
|
|
 |
Pregabalin Impurity 8 |
44996-52-3 |
C7H11NO3 |
 |
Pregabalin Impurity 14 |
1610546-44-5 |
C7H11NO3 |
 |
Cefditoren Impurity 1 |
|
|
 |
Cefadroxil Impurity C |
79962-91-7 |
C16H17N3O5S |
 |
Pralatrexate Impurity 8 |
112408-16-9 |
C8H15NO4 |
 |
Pitavastatin Impurity 46 |
|
|
 |
Canagliflozin Impurity 46 |
|
|
 |
Lenvatinib Impurity 37 |
|
|
 |
Sitafloxacin Impurity 20 |
|
|
 |
posaconazole impurity 66 |
|
|
 |
Dapoxetine impurity 33 |
|
|
 |
Budesonide Impurity 4 |
|
|
 |
Canagliflozin Impurity 49 |
2243132-56-9 |
C34H35FO11S |
 |
Canagliflozin Impurity 55 |
|
|
 |
Rosuvastatin Impurity 74 |
|
|
 |
Tofacitinib Impurity 106 |
|
|
 |
Hydroxychloroquine Impurity J |
|
|
 |
Levetiracetam Impurity 25 |
|
|
 |
Levosimendan Impurity 7 |
|
|
 |
Cabozantinib impurity K |
|
|
 |
Crisaborole Impurity 8 |
|
|
 |
Trifluridine Impurity B |
|
|
 |
Rotigotine Impurity |
|
|
 |
Olprinone Impurity 2 |
106730-62-5 |
C14H12N4O2 |
 |
Nicorandil Impurity F |
|
|
 |
Nicorandil Impurity A |
|
|
 |
Evogliptin Impurity 1 |
|
|
 |
Ondansetron IMpurity 5 |
|
|
 |
Plerixafor Impurity 1 |
|
|
 |
PLANTAGININ |
26046-94-6 |
C21H20O11 |
 |
(3S,5S)-Fluvastatin Sodium Salt |
194935-01-8 |
C24H27FNNaO4 |
 |
バイカレイン6-O-グルコシド |
28279-72-3 |
C21H20O10 |
 |
Dolutegravir Glucoside |
|
|
 |
delphinidin 3-O-beta-D-glucoside |
50986-17-9 |
C21H21O12+ |
 |
エリオジクチオール-6-グルコシド |
118040-45-2 |
C21H22O11 |
 |
Rubrofusarin triglucoside |
245724-07-6 |
C33H42O20 |
 |
Recombinant Endo Beta-N-Acetylglucosaminidase (ENGASE) |
|
|
 |
RV Salmonella enrichment broth (Pharmacopoeia 2015 edition) |
|
|
 |
Pharmacopoeia experiment |
|
|
 |
bergaptol-O-glucopyranoside |
131623-13-7 |
C17H16O9 |
 |
Ethyl α-Thioglucopyranoside |
13533-58-9 |
C8H16O5S |
 |
クエルセチン 3‐ルチノシド 7‐グルコシド |
30311-61-6 |
C33H40O21 |
 |
Aurantio-obtusin-6-O-β-D-glucoside |
129025-96-3 |
C23H24O12 |
 |
Fluconazole impurity I(For Chinese Pharmacopiea) |
|
|
 |
3-(β-D-グルコピラノシルオキシ)-3',4',5,5',7-ペンタヒドロキシフラボン |
19833-12-6 |
C21H20O13 |
![2-(3,4-ジヒドロキシ-5-メトキシフェニル)-5,7-ジヒドロキシ-3-{[(2S,3R,4S,5S,6R)-3,4,5-トリヒドロキシ-6-(ヒドロキシメチル)オキサン-2-イル]オキシ}-1λ4-クロメン-1-イリウム](/CAS/20180808/GIF/71991-88-3.gif) |
2-(3,4-ジヒドロキシ-5-メトキシフェニル)-5,7-ジヒドロキシ-3-{[(2S,3R,4S,5S,6R)-3,4,5-トリヒドロキシ-6-(ヒドロキシメチル)オキサン-2-イル]オキシ}-1λ4-クロメン-1-イリウム |
71991-88-3 |
C22H23O12+ |
 |
テリモシド |
56316-75-7 |
C28H24O16 |
 |
Pinocembroside,Pinocembrin41-O-beta-D-glucoside |
|
|
 |
フラボサチバシド |
61360-94-9 |
C27H30O15 |
 |
プエラリン4′-O-グルコシド |
117047-08-2 |
C27H30O14 |
 |
ペオニンクロリド |
132-37-6 |
C28H33ClO16 |
 |
Recombinant N-Acetyl Alpha-D-Glucosaminidase (NAGLU) |
|
|
 |
Human N-acetyl-β-D-glucosaminida se,NAG ELISA Kit |
|
|
 |
(3R,5S)-フルバスタチンナトリウム塩 |
94061-80-0 |
C24H25FNNaO4 |
 |
Fluvastatin N-Ethyl Sodium Salt (Fluvastatin Impurity) |
93936-64-2 |
C23H23FNNaO4 |
 |
アロエエモジングルコシド |
29010-56-8 |
C21H20O10 |
 |
(+)-epipinoresinol-4-O-β-D-glucoside |
74983-66-7 |
C26H32O11 |
 |
エリオジクチオール-8-グルコシド |
153733-96-1 |
C21H22O11 |
 |
ナリンギン4′-グルコシド |
17257-21-5 |
C33H42O19 |
![(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone](/CAS/20211123/GIF/858127-38-5.gif) |
(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
858127-38-5 |
C26H32O12 |
![β-D-Glucopyranoside, [[(3R,3aS,6S,6aR)-tetrahydro-3a-hydroxy-1H,3H-furo[3,4-c]furan-3,6-diyl]bis(2-methoxy-4,1-phenylene)]bis](/CAS/20210305/GIF/112747-99-6.gif) |
β-D-Glucopyranoside, [[(3R,3aS,6S,6aR)-tetrahydro-3a-hydroxy-1H,3H-furo[3,4-c]furan-3,6-diyl]bis(2-methoxy-4,1-phenylene)]bis |
112747-99-6 |
C32H42O17 |
 |
N-acetyl-β-D-glucosidase |
|
|
 |
CetearylGlucoside |
246159-33-1 |
|
 |
Alpha-D-Methylglucoside |
|
|
 |
2-エトキシ-4-ホルミルフェニルβ-D-グルコピラノシド |
122397-96-0 |
C15H20O8 |
 |
ピノセンブロシド |
75829-43-5 |
C21H22O9 |
 |
Kaempferol-3-rhamnoglucoside-7-glucoside |
34336-18-0 |
C33H40O20 |
 |
2-O-cinnamoyl-beta-D-glucose |
|
|
 |
OEM Honey |
|
|
 |
(3R,5R)-Fluvastatin Sodium Salt |
194934-99-1 |
C24H27FNNaO4 |
 |
IRAS vials are low alkaline and meet the pharmacopoeia standards of various countries |
|
|
 |
(3S,5R)-Fluvastatin SodiuM Salt |
94061-81-1 |
C24H25FNNaO4 |
 |
MeropeneM iMpurity 7 |
|
|
 |
Brexpiprazole Impurity 34 |
2247155-42-4 |
C25H27N3O4S |
 |
Cabozantinib Impurity 5 |
104330-60-1 |
C11H12FNO3 |